concept

PHASE SEPARATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PHASE SEPARATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

35Connections

26Hypotheses

7Analyses

16Outgoing

19Incoming

11Experiments

9Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	PHASE SEPARATION

Pathway Diagram

graph TD
    PHASE_SEPARATION[PHASE SEPARATION]
    PHASE_SEPARATION -->|involved_in| Normal_Cell_Function[Normal Cell Function]
    PHASE_SEPARATION -->|mediates| stress_granule_formation[stress granule formation]
    PHASE_SEPARATION -->|involved_in| Stress_Granules[Stress Granules]
    PHASE_SEPARATION -->|involved_in| Stress_Granule_Formation[Stress Granule Formation]
    PHASE_SEPARATION -->|mediates| Condensate_Formation[Condensate Formation]
    PHASE_SEPARATION -->|contributes to| TDP_43_Aggregation[TDP-43 Aggregation]
    PHASE_SEPARATION -->|drives| DDR_foci_formation[DDR foci formation]
    PHASE_SEPARATION -->|mediates| stress_granules[stress granules]
    PHASE_SEPARATION -->|drives| protein_aggregation[protein aggregation]
    PHASE_SEPARATION -->|involved_in| STAU1_Condensate_Formation[STAU1 Condensate Formation]
    DNAJB6[DNAJB6] -->|regulates| PHASE_SEPARATION
    Repeat_Rna[Repeat Rna] -->|modulates| PHASE_SEPARATION
    TDP_43_Misfolding[TDP-43 Misfolding] -->|mediates| PHASE_SEPARATION
    RNA_G_quadruplexes[RNA G-quadruplexes] -->|regulates| PHASE_SEPARATION
    Tdp43_Low_Complexity_Domain[Tdp43 Low-Complexity Domain] -->|mediates| PHASE_SEPARATION
    SYNCRIP[SYNCRIP] -->|mediates| PHASE_SEPARATION
    Tp53Bp1[Tp53Bp1] -->|involved_in| PHASE_SEPARATION
    UBQLN2[UBQLN2] -->|involved_in| PHASE_SEPARATION
    Chemical_Modulators[Chemical Modulators] -->|modulates| PHASE_SEPARATION

Outgoing (16)

Target	Relation	Type	Str
Normal Cell Function	involved_in	phenotype	0.95
stress granule formation	mediates	process	0.94
DDR foci formation	drives	process	0.90
stress granules	mediates	process	0.90
Stress Granule Formation	associated_with	process	0.90
Stress Granules	involved_in	process	0.90
Condensate Formation	mediates	mechanism	0.90
TDP-43 Aggregation	contributes_to	mechanism	0.90
protein aggregation	drives	process	0.90
STAU1 Condensate Formation	involved_in	mechanism	0.85
PABP1	associated_with	protein	0.85
amyloid-like aggregation	causes	mechanism	0.70
53BP1-mediated recruitment	causes	process	0.70
super-enhancer signal amplification	regulates	phenotype	0.70
biomolecular condensates	forms	structure	0.70
super-enhancer signal integration	regulates	phenotype	0.70

Incoming (19)

Source	Relation	Type	Str
DNAJB6	regulates	protein	0.93
TDP-43 Misfolding	mediates	mechanism	0.90
Tdp43 Low-Complexity Domain	mediates	protein	0.90
33967699	undergo	paper	0.90
G3BP1	activates	protein	0.90
Repeat Rna	modulates	compound	0.90
FUS MUTATIONS	disrupts	gene	0.90
RNA G-quadruplexes	regulates	process	0.90
SYNCRIP	mediates	protein	0.85
Phosphorylation	associated_with	process	0.85
Tp53Bp1	involved_in	protein	0.85
UBQLN2	involved_in	protein	0.85
Chemical Modulators	modulates	compound	0.80
FUS	drives	gene	0.70
Dipeptide Repeat Proteins	disrupts	protein	0.70
arginine-rich_DPRs	inhibits	protein	0.70
Low Complexity Domains	regulates	protein	0.70
33967699	impacts	paper	0.60
33967699	may impact	paper	0.60

Targeting Hypotheses (26)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P	0.868	als	-
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43	0.820	neurodegeneration	What is the therapeutic window between i
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi	0.783	neurodegeneration	-
Stress Granule Phase Separation Modulators	0.720	neurodegeneration	RNA binding protein dysregulation across
TRIM21 as a 'Phase Separation Thermostat' via Catalytic Reve	0.700	neurodegeneration	How does TRIM21-mediated K63 ubiquitinat

FUS Phase Separation Dominance in FTD-TDP: Aberrant Condensa	0.683	frontotemporal-dementia	-
TDP-43 Liquid-Liquid Phase Separation Dominance in Stress Gr	0.650	alzheimers	-
p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle	0.649	neurodegeneration	How do different organelle-specific auto
Small Molecule Modulation of Phase Separation	0.640	neurodegeneration	What determines the specificity of RNA-p
Hierarchical Phase Separation with Scaffold Cores	0.630	neurodegeneration	What determines the specificity of RNA-p
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Biophysical Determinants Shifting FUS/TD
Cell-state stratification is required to resolve Biophysical	0.612	neurodegeneration	Biophysical Determinants Shifting FUS/TD
ALS-Associated G3BP1 Mutations Shift Phase Separation Equili	0.610	neurodegeneration	How do disease-associated mutations in G
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Biophysical Determinants Shifting FUS/TD
Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Sepa	0.565	neurodegeneration	Test
Liquid-Liquid Phase Separation Modifier Therapy	0.551	neurodegeneration	Protein aggregation cross-seeding across
TDP-43 Phase Separation Destabilization Drives Cytoplasmic A	0.500	neurodegeneration	Test
Liquid-Liquid Phase Separation (LLPS) Saturation Partitionin	0.461	neurodegeneration	What determines the spatial organization
RNA Granule Phase Separation as Transient Cross-Seeding Hub	0.455	neurodegeneration	Protein aggregation cross-seeding across
Phase Separation Modulation Therapy	0.455	neurodegeneration	How do host cell factors influence the c
Nuclear Import Receptor Enhancers as Phase Separation Modula	0.000	-	TDP-43 phase separation therapeutics for
ATP-Mimetic Phase Separation Modulators	0.000	-	TDP-43 phase separation therapeutics for
Targeting TDP-43 Phase Separation Through Selective RNA-Bind	0.000	-	-
Bi-functional Nuclear Trafficking-Phase Separation Modulator	0.000	-	TDP-43 phase separation therapeutics for
Phase Separation Modifier Compounds	0.000	-	How do dilncRNAs specifically drive mole

Mentioning Analyses (7)

Scientific analyses that reference this entity

Biophysical Determinants Shifting FUS/TDP-43 Phase Separation to Pathological Ag

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.680

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.720

Do different priming stimuli create distinct chromatin landscapes or converge on

epigenetics | 2026-04-10 | 3 hypotheses

What physicochemical properties determine selective protein recruitment vs exclu

molecular biology | 2026-04-10 | 3 hypotheses Top: 0.583

How do host cell factors influence the conformation and propagation properties o

neurodegeneration | 2026-04-08 | 7 hypotheses Top: 0.455

Experiments (11)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
G3BP1-mediated stress granule assembly via liquid-liquid phase separat	exploratory		0.900	0.00	eukaryotic cells	proposed	N/A
TRIM21 E3 ubiquitin ligase screen for stress granule regulation	exploratory	neurodegenerative diseases	0.900	0.00	cultured cells	proposed	N/A
G3BP1 intrinsically disordered region analysis and phosphorylation eff	exploratory		0.850	0.00	in vitro protein analysis syst	proposed	N/A
G3BP1-binding factor cooperativity in stress granule network regulatio	exploratory		0.800	0.00	cell culture systems with prot	proposed	N/A
Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
Multiscale Computational Modeling of Protein Aggregation Kinetics	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,280,000
Pre-Symptomatic Detection and Intervention Timing in Genetic Prion Dis	validation	ALS	0.400	0.50	human	proposed	$2,280,000
Protein Aggregation Kinetic Validation Results	validation	Neurodegeneration	0.400	0.50	in_silico	proposed	$120,000
Stress Granule Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3B [PMID:36692217]	Yang C, Wang Z, Kang Y, Yi Q, Wang T, Ba	Autophagy	2023	3
G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Gran [PMID:32302571]	Yang P, Mathieu C, Kolaitis RM, Zhang P,	Cell	2020	3
LINC00599 Promotes Pulmonary Hypertension via Liquid-Liquid Phase Separation Wit [PMID:40693377]	Wang Y, Yin L, Zheng S, Liu A, Liu C, Ba	Hypertension	2025	1
The important role of stress granules in prostate cancer development, progressio [PMID:40972860]	Xu Z, You H, Gu J, Jiang J, Yan Z, Jin X	Gene	2025	1
Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specifi [PMID:34739333]	Gwon Y, Maxwell BA, Kolaitis RM, Zhang P	Science	2021	1
STING is the scaffold protein for stress granule pre-condensation at the ER. [PMID:41917183]	Eom E, Kim J, Kim J, Kang SJ	Cell death and differentiation	2026	0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077]	["Desai M", "Gulati K", "Agrawal M", "Gh	Neural regeneration research	2026	0
WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity [PMID:41915747]	Li Z, Wang Y, Chen Z, Liu R, Lai ZH, Li	Proceedings of the National Ac	2026	0
NUP93 facilitates the nuclear import of SOX2 to activate G3BP1 transcription and [PMID:41896201]	Sun H, Yang C, Du J, Xu C, Chen Y, Chen	Cell death & disease	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Translational neurodegeneratio	2026	0
Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by sup [PMID:41920932]	Mulloy RP, Evseev D, Sharlin N, Bui-Mari	PLoS biology	2026	0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077]	Desai M, Gulati K, Agrawal M, Ghumra S,	Neural Regen Res	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Transl Neurodegener	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Front Pharmacol	2026	0
Stress granules at the crossroads of retroviral replication and antiviral immuni [PMID:41931190]	Akbarin MM, Farjami Z, Álvarez HR	Mol Biol Rep	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Frontiers in pharmacology	2026	0
Disruption of G3BP1 granules promotes mammalian CNS and PNS axon regeneration. [PMID:40014573]	["Sahoo P", "Agrawal M", "Hanovice N", "	Proceedings of the National Ac	2025	0
RIOK1 phase separation restricts PTEN translation via stress granules activating [PMID:40467995]	["Meng F", "Li H", "Huang Y", "Wang C",	Nature cancer	2025	0
β-propeller protein-associated neurodegeneration protein WDR45 regulates stress [PMID:40473629]	["Li Y", "Fang J", "Ding Y", "Zhang X",	Nature communications	2025	0
Identification of small molecule inhibitors of G3BP-driven stress granule format [PMID:38284934]	["Freibaum B", "Messing J", "Nakamura H"	The Journal of cell biology	2024	0

Debates (9)

Multi-agent debates referencing this entity

What are the biophysical determinants — RNA binding stoichiometry, post-translat

closed · Rounds: 4 · Score: 0.67 · 2026-04-28

Debate: Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

closed · Rounds: 4 · Score: 0.58 · 2026-04-27

While the study identifies G3BP1 as a central node triggering phase separation,

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

The debate identified this as the core knowledge gap but provided no mechanistic

closed · Rounds: 4 · Score: 0.71 · 2026-04-21

The debate presented conflicting evidence for convergent vs. stimulus-specific c

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The abstract reveals FUS has a chaperone-like function regulating TAZ condensate

closed · Rounds: 4 · Score: 0.81 · 2026-04-16

TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small

closed · Rounds: 6 · Score: 0.84 · 2026-04-12

TDP-43 phase separation therapeutics for ALS-FTD

closed · Rounds: 4 · Score: 0.95 · 2026-04-11

How do host cell factors influence the conformation and propagation properties o

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Related Research

Hypotheses and analyses mentioning PHASE SEPARATION in their description or question text

p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinat

Score: 0.649 · neurodegeneration · 2026-04-21

## Mechanistic Overview p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinated Autophagy sta

Small Molecule Modulation of Phase Separation

Score: 0.640 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The therapeutic strategy centers on modulating liquid-liquid phase separation (LL

Hierarchical Phase Separation with Scaffold Cores

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The hierarchical phase separation model proposes a sophisticated two-tier mechani

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

Cell-state stratification is required to resolve Biophysical Determinants Shifti

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: FUS, TDP-43, RNA. Averaging a

ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberran

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberrant Condensate Sta

Perturbation-first validation should precede therapeutic claims for Biophysical

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD

Score: 0.565 · neurodegeneration · 2026-05-10

High-throughput screening for compounds that restore proper TDP-43 granule dynamics by preventing pathological liquid-to

Liquid-Liquid Phase Separation Modifier Therapy

Score: 0.551 · neurodegeneration · 2026-04-02

Compounds that modulate the surface tension and composition of biomolecular condensates could prevent the aberrant mixin

TDP-43 Phase Separation Destabilization Drives Cytoplasmic Aggregation

Score: 0.500 · neurodegeneration · 2026-05-03

Aberrant arginine methylation prevents TDP-43 liquid-liquid phase separation, promoting pathogenic aggregation. PRMT5-me

Liquid-Liquid Phase Separation (LLPS) Saturation Partitioning Excludes Autophagy

Score: 0.461 · neurodegeneration · 2026-04-21

## Mechanistic Overview Liquid-Liquid Phase Separation (LLPS) Saturation Partitioning Excludes Autophagy Receptors from

RNA Granule Phase Separation as Transient Cross-Seeding Hub

Score: 0.455 · neurodegeneration · 2026-04-27

Liquid-liquid phase separation of RNA-binding proteins (TDP-43, FUS) creates membrane-less compartments where disease-sp

PHASE SEPARATION

Understanding Entity Pages

Pathway Diagram

Outgoing (16)

Incoming (19)

Targeting Hypotheses (26)

Mentioning Analyses (7)

Biophysical Determinants Shifting FUS/TDP-43 Phase Separation to Pathological Ag

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

Do different priming stimuli create distinct chromatin landscapes or converge on

What physicochemical properties determine selective protein recruitment vs exclu

How do host cell factors influence the conformation and propagation properties o

What determines the specificity of RNA-protein interactions that drive distinct

TDP-43 phase separation therapeutics for ALS-FTD

Experiments (11)

Related Papers (20)

Debates (9)

What are the biophysical determinants — RNA binding stoichiometry, post-translat

Debate: Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

While the study identifies G3BP1 as a central node triggering phase separation,

The debate identified this as the core knowledge gap but provided no mechanistic

The debate presented conflicting evidence for convergent vs. stimulus-specific c

The abstract reveals FUS has a chaperone-like function regulating TAZ condensate

TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small

TDP-43 phase separation therapeutics for ALS-FTD

How do host cell factors influence the conformation and propagation properties o

Related Research

p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinat

Small Molecule Modulation of Phase Separation

Hierarchical Phase Separation with Scaffold Cores

RNA-binding protein condensate maturation from reversible phase separation to am

RNA-binding protein condensate maturation from reversible phase separation to am

Cell-state stratification is required to resolve Biophysical Determinants Shifti

ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberran

Perturbation-first validation should precede therapeutic claims for Biophysical

Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD

Liquid-Liquid Phase Separation Modifier Therapy

TDP-43 Phase Separation Destabilization Drives Cytoplasmic Aggregation

Liquid-Liquid Phase Separation (LLPS) Saturation Partitioning Excludes Autophagy

RNA Granule Phase Separation as Transient Cross-Seeding Hub